Probiotics: Moving Beyond Digestion

  • Thursday, 09/14/2017: 3:30 PM - 4:30 PM
  • Room: Baltimore Convention Center, Room 321

  • Sponsored by:  


The presentation begins with a brief history of probiotic research and development, focusing on key discoveries that paved the way for current interests in bacteriophage technology, probiotic-gastrointestinal immunity, and the neurohormonal relationship between the gut flora and central nervous system.

Bacteriophage Technology and Its Implementation into Probiotic Formulas

Better understanding of the biochemical relationships between undesirable intestinal bacterial strains and healthy strains, lead to the hypothesis that standard probiotic formulas, although beneficial, may not be as effective as once believed. This discovery reinvigorated research into bacteriophages and their potential implementation into probiotic formulas. The lecture will review bacteriophage research and will investigate the potential synergistic effects of a potential, dual-action probiotic formula.

Probiotic-gastrointestinal Immunity

Cold and flu season always stirs up the vaccine debate, and in the 2017-2018 season the debate will intensify with the new adverse reporting data of anti-viral medications. The time is ripe for the natural medicine industry to develop safe and effective therapies that target the frequency, severity, and duration of colds and flus and boost the immune system. The lecture will review current research on a blend of specific probiotic strains – L. plantarum, L. rhamnosus, and B. lactis – on enhancing intestinal mucosal defenses through activating immunoglobulin secretion.

Embryonic Gut-Brain Connection

The lecture will review the embryonic development of the gut-brain connection. Understanding the connection can have a tremendous impact on chronic inflammation, leaky gut syndrome, and related mood disorders. Currently, conventional therapy of mood disorders are largely ineffective and come with a myriad of side effects. The lecture will review probiotic research, which applies knowledge about the body’s “second brain.” This has led to safer treatments of mood disorder and inflammatory conditions.

Learning Objectives

Attendees will learn about the latest trends and research developments in probiotic therapy, including updates in bacteriophage technology and its implementation in probiotic formulas, the latest findings in probiotic-gastrointestinal immunity and the influence on mucosal immunoglobulin secretion, and an in depth review of the embryonic gut-brain connection and the implication for safer treatment options of mood disorders.


Michael A. Smith, M.D.

Senior Health Scientist
Life Extension®